Bernard R. Chaitman

Learn More
ADVANCE ONLINE PUBLICATION | 1 Department of Cardiology, Aarhus University Hospital, Tage-Hansens Gade 2, DK-8000 Aarhus C, Denmark (K. Thygesen). Department of Medicine, University of Arizona College of Medicine, 1501 N. Campbell Avenue, P. O. Box 245037, Tucson, AZ 85724, USA (J. S. Alpert). Green Lane Cardiovascular Service, Auckland City Hospital,(More)
Chairpersons: Kristian Thygesen (Denmark)*, Joseph S. Alpert (USA)*, Harvey D. White (New Zealand)* Biomarker Group: Allan S. Jaffe, Coordinator (USA), Fred S. Apple (USA), Marcello Galvani (Italy), Hugo A. Katus (Germany), L. Kristin Newby (USA), Jan Ravkilde (Denmark) ECG Group: Bernard Chaitman, Co-ordinator (USA), Peter M. Clemmensen (Denmark), Mikael(More)
The purpose of this report is to provide revised standards and guidelines for the exercise testing and training of individuals who are free from clinical manifestations of cardiovascular disease and those with known cardiovascular disease. These guidelines are intended for physicians, nurses, exercise physiologists, specialists, technologists, and other(More)
BACKGROUND In patients with stable coronary artery disease, it remains unclear whether an initial management strategy of percutaneous coronary intervention (PCI) with intensive pharmacologic therapy and lifestyle intervention (optimal medical therapy) is superior to optimal medical therapy alone in reducing the risk of cardiovascular events. METHODS We(More)
WRITING COMMITTEE MEMBERS Douglas P. Zipes, MD, MACC, FAHA, FESC, Co-Chair; A. John Camm, MD, FACC, FAHA, FESC, Co-Chair; Martin Borggrefe, MD, FESC; Alfred E. Buxton, MD, FACC, FAHA; Bernard Chaitman, MD, FACC, FAHA; Martin Fromer, MD; Gabriel Gregoratos, MD, FACC, FAHA; George Klein, MD, FACC; Arthur J. Moss, MD, FACC, FAHA†; Robert J. Myerburg, MD, FACC,(More)
BACKGROUND In patients with established cardiovascular disease, residual cardiovascular risk persists despite the achievement of target low-density lipoprotein (LDL) cholesterol levels with statin therapy. It is unclear whether extended-release niacin added to simvastatin to raise low levels of high-density lipoprotein (HDL) cholesterol is superior to(More)
Writing Committee Members, Douglas P. Zipes, MD, MACC, FAHA, FESC, Co-Chair, A. John Camm, MD, FACC, FAHA, FESC, Co-Chair, Martin Borggrefe, MD, FESC, Alfred E. Buxton, MD, FACC, FAHA, Bernard Chaitman, MD, FACC, FAHA, Martin Fromer, MD, Gabriel Gregoratos, MD, FACC, FAHA, George Klein, MD, FACC, Arthur J. Moss, MD, FACC, FAHA Robert J. Myerburg, MD, FACC,(More)
Copyright © 2002 American Heart Association. All rights reserved. Print ISSN: 0009-7322. Online Circulation is published by the American Heart Association. 7272 Greenville Avenue, Dallas, TX 72514 2002;105;1257-1267 Circulation Sidney C. Smith, Jr Gabriel Gregoratos, Alice K. Jacobs, Loren F. Hiratzka, Richard O. Russell and J. Gibbons, Elliott M. Antman,(More)